Breaking News

Astellas Adds Executives

May 5, 2014

Zeiher and Barrett to head Global Development and Medical Affairs

Bernhardt Zeiher, M.D. has been appointed executive vice president of Global Development at Astellas and Jeannette A. Barrett, Ph.D., has been named vice president and head of Medical Excellence, Global Medical Affairs.
 
Dr. Zeiher will be responsible for Global Development Operations and Global Clinical Pharmacology and Exploratory Development (GCPED), in addition to serving as therapeutic area head of Immunology, Infectious Disease, Transplant, Central Nervous System and Pain. He will continue to report to Dr. Sef Kurstjens, chief medical officer and president of Global Development. Dr. Zeiher has more than 15 years of experience in the pharma industry. Most recently he was vice president of the inflammation/immunology therapeutic area at Pfizer.

Dr. Barrett will be responsible for supporting medical affairs activities globally and providing the tools, processes, systems and infrastructure to ensure transparency, operational consistency, limit risk and improve compliance. Dr. Barrett will report to Dr. Charlotte Kremer, senior vice president and head, Global Medical Affairs. Dr. Barrett has more than 20 years of experience in the areas of medical affairs, regulatory affairs and drug safety having held leadership roles at several global pharmaceutical companies, including Pfizer, where she spent 16 years.
 
"Both Bernie and Jeannette's global experience, along with their pharmaceutical and clinical knowledge, make them perfect fits for Astellas," said Kurstjens. "We are delighted to be promoting Bernie and bringing Jeannette on to the Astellas team to further our mission of bringing important treatment options to patients."
 

blog comments powered by Disqus
  • Cold Chain Packaging Trends

    Cold Chain Packaging Trends

    Kristin Brooks, Contract Pharma||February 4, 2016
    Susan Li of UPS discusses supply chain trends, challenges, and packaging innovations

  • Packaging Equipment Trends Preview

    Packaging Equipment Trends Preview

    Kristin Brooks, Contract Pharma||January 26, 2016
    Christian Treitel of Bosch Packaging Technology discusses trends and capabilities

  • Tackling Drug Serialization Challenges

    Tackling Drug Serialization Challenges

    Tim Wright, editor||January 22, 2016
    Siemens and Adents together will develop a combined hardware plus software solution for pharma industry

  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016